Pulmonary Hypertension Associated with Use of Phentermine

Cardiology Division, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
Yonsei medical journal (Impact Factor: 1.29). 11/2010; 51(6):971-3. DOI: 10.3349/ymj.2010.51.6.
Source: PubMed


Weight-control drugs (known as anorexigens) such as fenfluramine have been linked with pulmonary hypertension in previous reports. In our case, a 29 year old woman was admitted for shortness of breath and was diagnosed with pulmonary hypertension. Three months ago, she had been taking phentermine for five weeks. Other factors that might have contributed to the development of pulmonary hypertension were excluded. With treatment, her symptoms improved. This is the first case that can suggest a possible connection between phenermine single medication with pulmonary hypertension. Phentermine has been considered a relatively safe drug to treat obesity, and further investigation is needed to decide the safety and dosage of phentermine.

Download full-text


Available from: Boyoung Joung
  • [Show abstract] [Hide abstract]
    ABSTRACT: This review of the 2010 publications on adverse reactions to central nervous system stimulants and drugs that suppress appetite covers amphetamines (amfetamine, dexamfetamine, and metamfetamine), benfluorex (in a special review), atomoxetine, methylphenidate, modafinil, methylxanthines (caffeine and theobromine), phentermine, sibutramine, rimonabant, tesofensine, and drugs used in Alzheimer's disease (donepezil, memantine, and rivastigmine). Benfluorex, an appetite suppressant structurally related to fenfluramine, was used for the management of obesity and to improve glycemic control and reduce insulin resistance in patients with poorly controlled type 2 diabetes mellitus. It has been estimated that several million people were exposed to benfluorex before its recent withdrawal because of adverse reactions. Cases of valvular heart disease and cases of pulmonary hypertension associated with benfluorex are reviewed. Other stimulants, such as methylphenidate, used in the treatment of attention deficit hyperactivity disorder, are discussed. Newer insights on methylxanthine toxicity due to genetic susceptibility and regulatory policy changes on sibutramine, in view of cardiovascular safety concerns, are reviewed. An update on drugs used in Alzheimer's disease is also provided.
    No preview · Article · Jan 2011 · Side Effects of Drugs Annual
  • Source

    Full-text · Article · Sep 2011 · Yonsei medical journal
  • [Show abstract] [Hide abstract]
    ABSTRACT: According to international surveys, the appetite suppressant phentermine has frequently been seized although its approval has been withdrawn in Germany. Phentermine is an isomer of methamphetamine though is not optically active such as e. g. amphetamine. The drug acts as a potent substrate at the norepinephrine transporter simultaneously promoting its release; it has a weaker activity at the dopamine transporter whereas its activity towards the serotonin transporter is negligible. Overall, its pharmacological action is comparable to that of amphetamine albeit less strong. Due to its declining effect with time and its addiction potential it has been recommended that phentermine should be used for a few weeks only. Phentermine hydrochloride is a readily soluble salt; absorption of the resinate compound is considerably slower. The drug is not extensively biotransformed; p- and N-hydroxyphentermine are the primary metabolites also being excreted as glucuronide conjugates. Gas chromatographic techniques to identify and to quantify phentermine in biological specimens are applicable following derivatization; however, liquid chromatography coupled to mass spectrometry is currently preferred for analysis of urine, serum or hair. Short-term clinical studies having been performed in the 80s and 90s revealed no serious harmful side effects. However, there are case reports proposing that phentermine usage might be associated with severe health risks due to hypertension, vasoconstriction and vasculopathy; in some individuals, mental illness had been observed. Apart from the legal consequences following purchase of drugs that have been withdrawn its user will simultaneously run serious and unpredictable health risks.
    No preview · Article · May 2013 · Archiv für Kriminologie
Show more